1. Home
  2. CYBN vs ATOM Comparison

CYBN vs ATOM Comparison

Compare CYBN & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • ATOM
  • Stock Information
  • Founded
  • CYBN 2019
  • ATOM 2001
  • Country
  • CYBN Canada
  • ATOM United States
  • Employees
  • CYBN N/A
  • ATOM N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • ATOM Semiconductors
  • Sector
  • CYBN Health Care
  • ATOM Technology
  • Exchange
  • CYBN Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • CYBN 176.5M
  • ATOM 155.4M
  • IPO Year
  • CYBN N/A
  • ATOM 2016
  • Fundamental
  • Price
  • CYBN $6.08
  • ATOM $3.37
  • Analyst Decision
  • CYBN Strong Buy
  • ATOM
  • Analyst Count
  • CYBN 3
  • ATOM 0
  • Target Price
  • CYBN $85.00
  • ATOM N/A
  • AVG Volume (30 Days)
  • CYBN 621.7K
  • ATOM 275.1K
  • Earning Date
  • CYBN 11-12-2025
  • ATOM 10-28-2025
  • Dividend Yield
  • CYBN N/A
  • ATOM N/A
  • EPS Growth
  • CYBN N/A
  • ATOM N/A
  • EPS
  • CYBN N/A
  • ATOM N/A
  • Revenue
  • CYBN N/A
  • ATOM $49,000.00
  • Revenue This Year
  • CYBN N/A
  • ATOM $202.22
  • Revenue Next Year
  • CYBN N/A
  • ATOM $100.00
  • P/E Ratio
  • CYBN N/A
  • ATOM N/A
  • Revenue Growth
  • CYBN N/A
  • ATOM N/A
  • 52 Week Low
  • CYBN $4.81
  • ATOM $2.31
  • 52 Week High
  • CYBN $13.88
  • ATOM $17.55
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 38.92
  • ATOM 43.83
  • Support Level
  • CYBN $6.16
  • ATOM $3.17
  • Resistance Level
  • CYBN $6.55
  • ATOM $3.43
  • Average True Range (ATR)
  • CYBN 0.49
  • ATOM 0.19
  • MACD
  • CYBN -0.06
  • ATOM 0.07
  • Stochastic Oscillator
  • CYBN 12.90
  • ATOM 54.39

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.

Share on Social Networks: